Comparison of international blood pressure guidelines

Guidelines on the choice of agents and how best to step up treatment for various subgroups in hypertension (high blood pressure) have changed over time and differ between countries.

A Comparison of International Guidelines on Goal Blood Pressure and Initial Therapy for Adults With Hypertension (adapted from JNC 8 guidelines ^[1] )

Guideline	Population	Goal blood pressure (mmHg)	Initial treatment options
AHA/ACC 2025 [2]	General	<130/80	BP ≥140/90: Two from different classes: thiazide diuretic, long-acting dihydropyridine CCB, and ACEi or ARB BP ≥130/80: One of: thiazide diuretic, long-acting dihydropyridine CCB, ACEi or ARB
ESC 2024 [3]	General	120–129/70–79	BP >140/90: Two from different classes: preferably RAS-inhibitor (ACEi or ARB) with either thiazide diuretic/thiazide-like diuretic or dihydropyridine CCB
ESH 2023 [4]	Age <65 Age 65–79 Age ≥80	<130/80 <140 SBP <150 SBP	BP <150/95: Lifestyle changes BP ≥150/95 or has CVD risk factors or failed lifestyle changes: Two from different classes: thiazide-type diuretic, ACEi/ARB, and/or CCB
AAFP 2022 [5] [6]	General	<140/90	BP >140/90 and low-risk for CVD: Lifestyle changes BP >140/90 and CVD risk factors or failed lifestyle changes: monotherapy with thiazide-type diuretic, ACEi/ARB, and/or CCB BP >160/100: Two from different classes: thiazide-type diuretic, ACEi/ARB, and/or CCB
WHO 2021 [7]	General High CVD risk, diabetes or CKD Previous CVD	<140/90 <130 SBP <130 SBP	BP ≥140/90 and low-risk for CVD: Two from different classes: thiazide-type diuretic, ACEi/ARB, and/or CCB SBP ≥130 and CVD risk factors, diabetes or CKD: Two from different classes: thiazide-type diuretic, ACEi/ARB, and/or CCB SBP ≥130 and previous CVD: Two from different classes: thiazide-type diuretic, ACEi/ARB, and/or CCB
KDIGO 2021 [8]	CKD with kidney transplant	<120 SBP <130/80	CKD: ACEi/ARB Kidney transplant: ARB or CCB
ISH 2020 [9]	General Age <65 Age ≥65	<140/90 (reduction by at least 20/10) <130/80 <140/90	BP >140/90 and low-risk for CVD: Lifestyle changes BP >140/90 and CVD risk factors or failed lifestyle changes: monotherapy with thiazide-type diuretic, ACEi/ARB, and/or CCB BP >160/100: Two from different classes: thiazide-type diuretic, ACEi/ARB, and/or CCB
VA/DoD 2020 [10]	General Age ≥60 Age ≥60 with diabetes	<130/90 <150/90 <140/90	Thiazide-type diuretic, ACEi/ARB, and/or CCB Black: avoid monotherapy with ACEi/ARB
NICE 2019 [11]	Age <80 Age ≥80	<140/90 <150/90	Age <55: ACEi/ARB Age ≥55 or black: CCB
ADA 2018 [12]	Diabetes Diabetes with CVD risk	<140/90 <130/80	ACEi/ARB, thiazide-like diuretic, and/or dihydropyridine CCB
ESC/ESH 2018 [13]	Age <65 Age ≥65	<130/80 <140/80	Thiazide-type diuretic, ACEi/ARB, and/or CCB CAD: add beta-blocker Resistant hypertension: add spironolactone
ACC/AHA 2017 [14]	General	<130/80	BP > 130/80: Lifestyle changes and monotherapy with thiazide-type diuretic, ACEi/ARB, and/or CCB BP >20/10 above target: Lifestyle changes and two from different classes: thiazide-type diuretic, ACEi/ARB, and/or CCB
JNC 8 2013 [1]	General age ≥60 General age <60 Diabetes CKD	<150/90 <140/90 <140/90 <140/90	Non-black: thiazide-type diuretic, ACEi/ARB, and/or CCB Black: thiazide-type diuretic, and/or CCB Diabetes: thiazide-type diuretic, ACEi/ARB, and/or CCB CKD: ACEi/ARB
CHEP 2013 [15]	General age <80 General age ≥80 Diabetes CKD	<140/90 <150/90 <130/80 <140/90	General: thiazide-type diuretic, beta-blocker (age < 60), ACEi (non-black) or ARB Diabetes with additional risk : ACEi/ARB Diabetes without additional risk : ACEi/ARB, thiazide, or DHPCCB CKD: ACEi, or ARB
ISHIB 2010 [16]	Black, lower risk Target organ damage or CVD risk	<135/85 <130/80	Diuretic or CCB

Abbreviations:

• ACEi – angiotensin-converting enzyme inhibitor
• ARB – angiotensin receptor blocker
• BP – blood pressure
• CCB – calcium channel blocker
• DHPCCB – dihydropyridine calcium channel blocker
• CKD – chronic kidney disease
• CVD – cardiovascular disease
• SBP – systolic blood pressure

References

1. James, PA.; Oparil, S.; Carter, BL.; Cushman, WC.; Dennison-Himmelfarb, C.; et al. (Dec 2013). "2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)". JAMA. 311 (5): 507–20. doi:10.1001/jama.2013.284427. PMID   24352797.
2. Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, Abdalla M, et al. (16 September 2025). "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". Circulation. 152 (11): e114 –e218. doi: 10.1161/CIR.0000000000001356 . PMID   40811497.
3. McEvoy, John William; McCarthy, Cian P; Bruno, Rosa Maria; Brouwers, Sofie; Canavan, Michelle D; et al. (2024-08-30). "2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO)". European Heart Journal. 45 (38): 3912–4018. doi: 10.1093/eurheartj/ehae178 . ISSN   0195-668X. PMID   39210715.
4. Mancia, Giuseppe; Kreutz, Reinhold; Brunström, Mattias; Burnier, Michel; Grassi, Guido; et al. (2023-12-01). "2023 ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)". Journal of Hypertension. 41 (12): 1874–2071. doi: 10.1097/HJH.0000000000003480 . hdl: 11379/603005 . ISSN   1473-5598. PMID   37345492.
5. Coles, Sarah; Fisher, Lynn; Lin, Kenneth W.; Lyon, Corey; Vosooney, Alexis A.; Bird, Melanie D. (December 2022). "Blood Pressure Targets in Adults With Hypertension: A Clinical Practice Guideline From the AAFP". American Family Physician. 106 (6): Online. ISSN   1532-0650. PMID   36521481.
6. Clarke, S. Lindsey (October 2023). "Hypertension in Adults: Initial Evaluation and Management". American Family Physician. 108 (4): 352–359. ISSN   1532-0650. PMID   37843942.
7. Guideline for the pharmacological treatment of hypertension in adults (PDF). World Health Organization (WHO). 2021. ISBN   9789240033993 . Retrieved 2024-05-26.
8. Cheung, Alfred K.; Chang, Tara I.; Cushman, William C.; Furth, Susan L.; Hou, Fan Fan; et al. (March 2021). "KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease". Kidney International. 99 (3): S1 –S87. doi: 10.1016/j.kint.2020.11.003 . PMID   33637192.
9. Unger, Thomas; Borghi, Claudio; Charchar, Fadi; Khan, Nadia A.; Poulter, Neil R.; et al. (2020-05-06). "2020 International Society of Hypertension Global Hypertension Practice Guidelines". Hypertension. 75 (6): 1334–1357. doi: 10.1161/HYPERTENSIONAHA.120.15026 . hdl: 10394/34842 . ISSN   0194-911X. PMID   32370572.
10. U.S. Department of Veterans Affairs. "VA/DoD clinical practice guideline for the diagnosis and management of hypertension in the primary care setting". VA/DoD Clinical Practice Guidelines. Retrieved 2024-03-25.
11. "Hypertension in adults: diagnosis and management |". National Institute for Health and Clinical Excellence (NICE). 2019-08-28. Retrieved 2024-03-24.
12. Passarella, Pasquale; Kiseleva, Tatiana A.; Valeeva, Farida V.; Gosmanov, Aidar R. (2018-08-01). "Hypertension Management in Diabetes: 2018 Update". Diabetes Spectrum. 31 (3): 218–224. doi:10.2337/ds17-0085. ISSN   1040-9165. PMC   6092891 . PMID   30140137.
13. Williams, Bryan; Mancia, Giuseppe; Spiering, Wilko; Agabiti Rosei, Enrico; Azizi, Michel; et al. (1 September 2018). "2018 ESC/ESH Guidelines for the management of arterial hypertension". European Heart Journal. 39 (33): 3021–3104. doi:10.1093/eurheartj/ehy339. PMID   30165516.
14. Whelton, Paul K.; Carey, Robert M.; Aronow, Wilbert S.; Casey, Donald E.; Collins, Karen J.; et al. (2018-05-15). "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults". Journal of the American College of Cardiology. 71 (19): e127 –e248. doi:10.1016/j.jacc.2017.11.006. PMID   29146535.
15. Hackam, Daniel G.; Quinn, Robert R.; Ravani, Pietro; Rabi, Doreen M.; Dasgupta, Kaberi; et al. (May 2013). "The 2013 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension". Canadian Journal of Cardiology. 29 (5): 528–542. doi:10.1016/j.cjca.2013.01.005. PMID   23541660.
16. Flack, John M.; Sica, Domenic A.; Bakris, George; Brown, Angela L.; Ferdinand, Keith C.; et al. (November 2010). "Management of High Blood Pressure in Blacks: An Update of the International Society on Hypertension in Blacks Consensus Statement" . Hypertension. 56 (5): 780–800. doi:10.1161/HYPERTENSIONAHA.110.152892. ISSN   0194-911X. PMID   20921433.